Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
434 | 15650 | 24.2 | 55% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
179 | 52887 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | Journal | 280 | 83% | 1% | 156 |
2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | Journal | 263 | 14% | 11% | 1694 |
3 | CEFEPIME | Author keyword | 111 | 51% | 1% | 156 |
4 | MEROPENEM | Author keyword | 111 | 43% | 1% | 195 |
5 | DORIPENEM | Author keyword | 102 | 71% | 1% | 82 |
6 | CHEMOTHERAPY | Journal | 80 | 17% | 3% | 423 |
7 | ERTAPENEM | Author keyword | 78 | 54% | 1% | 101 |
8 | JAPANESE JOURNAL OF ANTIBIOTICS | Journal | 57 | 69% | 0% | 49 |
9 | BURNS TRAUMA CRIT CARE | Address | 46 | 34% | 1% | 112 |
10 | PIPERACILLIN | Author keyword | 45 | 41% | 1% | 84 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CEFEPIME | 111 | 51% | 1% | 156 | Search CEFEPIME | Search CEFEPIME |
2 | MEROPENEM | 111 | 43% | 1% | 195 | Search MEROPENEM | Search MEROPENEM |
3 | DORIPENEM | 102 | 71% | 1% | 82 | Search DORIPENEM | Search DORIPENEM |
4 | ERTAPENEM | 78 | 54% | 1% | 101 | Search ERTAPENEM | Search ERTAPENEM |
5 | PIPERACILLIN | 45 | 41% | 1% | 84 | Search PIPERACILLIN | Search PIPERACILLIN |
6 | CEFPIROME | 37 | 61% | 0% | 40 | Search CEFPIROME | Search CEFPIROME |
7 | AMINOGLYCOSIDES | 34 | 18% | 1% | 171 | Search AMINOGLYCOSIDES | Search AMINOGLYCOSIDES |
8 | TAZOBACTAM | 30 | 45% | 0% | 50 | Search TAZOBACTAM | Search TAZOBACTAM |
9 | IMIPENEM | 30 | 25% | 1% | 102 | Search IMIPENEM | Search IMIPENEM |
10 | AMIKACIN | 29 | 23% | 1% | 114 | Search AMIKACIN | Search AMIKACIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BMY 28142 | 172 | 90% | 0% | 74 |
2 | MEROPENEM | 119 | 44% | 1% | 208 |
3 | AMINOGLYCOSIDE PLASMA LEVELS | 116 | 87% | 0% | 58 |
4 | NETILMICIN | 99 | 55% | 1% | 122 |
5 | BETA LACTAMASE STABILITY | 92 | 77% | 0% | 63 |
6 | CEFTAZIDIME | 90 | 27% | 2% | 291 |
7 | BETA LACTAM ANTIBIOTICS | 86 | 15% | 3% | 528 |
8 | GRAM NEGATIVE INFECTIONS | 85 | 73% | 0% | 65 |
9 | TARGET ATTAINMENT | 83 | 94% | 0% | 30 |
10 | CEPHALOSPORIN | 80 | 32% | 1% | 212 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | 280 | 83% | 1% | 156 |
2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 263 | 14% | 11% | 1694 |
3 | CHEMOTHERAPY | 80 | 17% | 3% | 423 |
4 | JAPANESE JOURNAL OF ANTIBIOTICS | 57 | 69% | 0% | 49 |
5 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 23 | 11% | 1% | 199 |
6 | CHEMIOTERAPIA | 12 | 18% | 0% | 62 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions | 2014 | 24 | 137 | 67% |
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug' | 2004 | 329 | 36 | 67% |
Comparative review of the carbapenems | 2007 | 170 | 97 | 75% |
Pharmacokinetic issues for antibiotics in the critically ill patient | 2009 | 154 | 143 | 55% |
THE IMPORTANCE OF PHARMACOKINETIC-PHARMACODYNAMIC SURROGATE MARKERS TO OUTCOME - FOCUS ON ANTIBACTERIAL AGENTS | 1995 | 293 | 41 | 63% |
CONTINUOUS INFUSION OF BETA-LACTAM ANTIBIOTICS | 1992 | 221 | 39 | 79% |
ONCE-DAILY AMINOGLYCOSIDE THERAPY | 1991 | 245 | 49 | 78% |
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics | 2009 | 69 | 55 | 76% |
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses | 1996 | 135 | 54 | 78% |
Clinical implications of antibiotic pharmacokinetic principles in the critically ill | 2013 | 27 | 117 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BURNS TRAUMA CRIT CARE | 46 | 34% | 0.7% | 112 |
2 | ANTIINFECT DEV | 33 | 35% | 0.5% | 76 |
3 | CLIN PHARMACOTHER Y | 26 | 49% | 0.2% | 38 |
4 | ANTI INFECT DEV | 13 | 45% | 0.1% | 22 |
5 | ANTIBIOT UNIT | 12 | 56% | 0.1% | 15 |
6 | BRISTOL ANTIMICROBIAL EVALUAT | 8 | 24% | 0.2% | 29 |
7 | MT AUBURN HOSP | 7 | 25% | 0.2% | 26 |
8 | ANTIBIOL | 7 | 36% | 0.1% | 16 |
9 | MED SCI CLIN BACTERIOL INFECT DIS | 6 | 80% | 0.0% | 4 |
10 | BIOL VET BIOQUIM BIOL MOLEC | 6 | 100% | 0.0% | 4 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020390 | GENTAMICIN//WEN PI TANG//GENTAMICIN INDUCED NEPHROTOXICITY |
2 | 0.0000019023 | FEBRILE NEUTROPENIA//NEUTROPENIA//SEGMENTED FILAMENTOUS BACTERIA |
3 | 0.0000015538 | BACTEROIDES FRAGILIS//CFIA//ANAEROBE |
4 | 0.0000015474 | ACINETOBACTER BAUMANNII//ESBL//EXTENDED SPECTRUM BETA LACTAMASE |
5 | 0.0000013679 | DIFFUSE PANBRONCHIOLITIS//AZITHROMYCIN//ROXITHROMYCIN |
6 | 0.0000013444 | OPAT//HOSPITAL AT HOME//OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY OPAT |
7 | 0.0000013115 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//TETRACYCLINES |
8 | 0.0000011591 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
9 | 0.0000009730 | PHOSPHOLIPIDOSIS//2 DEOXYSTREPTAMINE//AMINOGLYCOSIDES |
10 | 0.0000008256 | CARBENE COMPLEXES//1 BETA METHYLCARBAPENEM//AZETIDIN 2 ONES |